Myocardial fibrosis in hypertrophic cardiomyopathy: Accurate reflection of histopathological findings by CMR

JACC: Cardiovascular Imaging

Volumn 6, Issue 5, 2013, Pages 587-596

  Moravsky, Gil ^a   Ofek, Efrat ^b   Rakowski, Harry ^a   Butany, Jagdish ^b   Williams, Lynne ^a   Ralph Edwards, Anthony ^b   Wintersperger, Bernd J ^a,c   Crean, Andrew ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

cardiac magnetic resonance; histopathology; hypertrophic cardiomyopathy; late gadolinium enhancement; myocardial fibrosis

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTERY DYSPLASIA; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FIBROSING ALVEOLITIS; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MUSCLE RESECTION; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY; CARDIOMYOPATHY, HYPERTROPHIC; CICATRIX; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84877782271     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2012.09.018     Document Type: Article

References (30)

1. G.T. Lamke, R.D. Allen, W.D. Edwards, H.D. Tazelaar, G.K. Danielson Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy. A study of 204 cases (1996-2000) Cardiovasc Pathol 12 2003 149 158
2. B.J. Maron, T.J. Anan, W.C. Roberts Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy Circulation 63 1981 882 894
3. B.J. Maron, J.K. Wolfson, S.E. Epstein, W.C. Roberts Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy J Am Coll Cardiol 8 1986 545 557
4. S.E. Hughes The pathology of hypertrophic cardiomyopathy Histopathology 44 2004 412 427
5. L. Choudhury, H. Mahrholdt, A. Wagner Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 40 2002 2156 2164
6. R.J. Kim, D.S. Fieno, T.B. Parrish Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
7. D.S. Fieno, R.J. Kim, E.L. Chen, J.W. Lomasney, F.J. Klocke, R.M. Judd Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing J Am Coll Cardiol 36 2000 1985 1991
8. J.C. Moon, E. Reed, M.N. Sheppard The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264
9. D.H. Kwon, N.G. Smedira, E.R. Rodriguez Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia J Am Coll Cardiol 54 2009 242 249
10. C.J. Harrigan, D.C. Peters, C.M. Gibson Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging Radiology 258 2011 128 133
11. A.S. Flett, J. Hasleton, C. Cook Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance J Am Coll Cardiol Img 4 2012 150 156
12. B.J. Maron, W.J. McKenna, G.K. Danielson American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
13. S.F. Nagueh, S.M. Bierig, M.J. Budoff American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography J Am Soc Echocardiogr 24 2011 473 498
14. L.C. Amado, B.L. Gerber, S.N. Gupta Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model J Am Coll Cardiol 44 2004 2383 2389
15. H.D. Tazelaar, M.E. Billingham The surgical pathology of hypertrophic cardiomyopathy Arch Pathol Lab Med 111 1987 257 260
16. A.M. Varnava, P.M. Elliott, S. Sharma, W.J. McKenna, M.J. Davies Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease Heart 84 2000 476 482
17. K.R. Anderson, M.G. Sutton, J.T. Lie Histopathological types of cardiac fibrosis in myocardial disease J Pathol 128 1979 79 85
18. J.S. Krouwer Why Bland-Altman plots should use X, not (Y+X)/2 when X is a reference method Stat Med 27 2008 778 780
19. R.Y. Kwong, A. Farzaneh-Far Measuring myocardial scar by CMR J Am Coll Cardiol Img 4 2012 157 160
20. R.J. Kim, E. Wu, A. Rafael The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
21. R.Y. Kwong, H. Korlakunta Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability Top Magn Reson Imaging 19 2008 15 24
22. S. Nazarian, D.A. Bluemke, A.C. Lardo Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2005 2821 2825
23. A.S. Adabag, B.J. Maron, E. Appelbaum Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
24. R. Rubinshtein, J.F. Glockner, S.R. Ommen Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 51 58
25. M.S. Maron, E. Appelbaum, C.J. Harrigan Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy Circ Heart Fail 1 2008 184 191
26. J.C. Moon, W.J. McKenna, J.A. McCrohon, P.M. Elliott, G.C. Smith, D.J. Pennell Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567
27. D.R. Messroghli, A. Greiser, M. Fröhlich Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart J Magn Reson Imaging 26 2007 1081 1086
28. A.S. Flett, M.P. Hayward, M.T. Ashworth Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2011 138 144
29. G.D. Aquaro, P. Masci, F. Formisano Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity Am J Cardiol 105 2010 392 397
30. E. Appelbaum, B.J. Maron, S. Adabag Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy Circ Cardiovasc Imaging 5 2012 78 85